Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Aug 06, 2020 4:17pm

80 Views

Post# 31375369

todays trades

House Positions for C:VXL from 20200806 to 20200806

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
85 Scotia	100,000	10,000	0.10	39,307	3,784	0.096	60,693	-6,216
79 CIBC	20,105	2,010	0.10	4,000	380	0.095	16,105	-1,630
33 Canaccord	9,713	922	0.095	175	16	0.091	9,538	-906
1 Anonymous	55,500	5,367	0.097	53,000	5,300	0.10	2,500	-67
68 Leede	200	19	0.095	321	32	0.10	-121	13
19 Desjardins	2,000	210	0.105	4,200	430	0.102	-2,200	220
2 RBC	80,313	7,990	0.099	85,147	8,403	0.099	-4,834	413
89 Raymond James	0			5,713	542	0.095	-5,713	542
9 BMO Nesbitt	4,000	420	0.105	10,500	1,102	0.105	-6,500	682
7 TD Sec	336,232	32,590	0.097	405,700	39,539	0.097	-69,468	6,949
TOTAL	608,063	59,528	0.098	608,063	59,528	0.098	0	0